New

Product to Practice Webinar Series

Empowering Life Sciences Teams With Smarter Customer Engagement

AI-driven intelligence to align strategy and execution, optimize HCP engagement, and drive measurable impact.

Aktana powers intelligent customer engagement for 350+ brands with more than 1,000 deployments across top global life sciences companies.

New

Recognized as a Leader and Star Performer by Everest Group

AI-Driven Solutions for Every Life Sciences Team

Aktana’s intelligence layer powers commercial, medical, and medtech teams with AI-driven insights, orchestrated engagement, and strategic decision support—helping teams work smarter while ensuring compliance and full context.

Accelerate revenue with AI insights that connect engagement to brand KPIs.

Brand and Commercial Team Solutions

Empower your medical affairs teams with intelligent engagement solutions to drive critical HCP-centric activities.

Medical Affairs Solutions

Optimize commercial execution, account coordination & medical education programs with AI-powered insights and guidance.

MedTech Solutions

AI-Powered Recommendations.
Human-Led Decisions.

Dr. Lee prioritizes dosing insights over MOA data.
Boost engagement with Dr. Torres.
Oncology KOLs discuss your therapy at conferences.
Dr. Chang stopped prescribing—follow up with new data.
Affordability programs are in demand for your region.
Dr. Wilson engages most with real-world evidence.
Dr. Carter prescribes less of Drug ABC, more of Competitor Drug DEF.
Competitor drug adoption is rising in key accounts.
HCPs seek adherence support tools in your territory.
Dr. Brown watches videos but ignores emails.
CA pulmonologists prefer rep visits over digital.
Dr. Garcia prescribes more after peer discussions.
New rheumatology prescribing guidelines released.
Dr. Singh’s new prescriptions for Drug ABC are declining.
Follow up: Dr. Adams engages but hasn’t prescribed.
HCPs cite affordability as key reason for switching.
Dr. Sanchez opened your email but didn’t engage.
List of HCPs with urgent suggestions available.
Today’s pending actions: Follow up with key prescribers.
Dr. Patel prefers email; Dr. Kim prefers in-person.
Check: HCPs with no engagement in the last 6 months.